White matter hypoperfusion and damage in dementia: post-mortem assessment

Area of Science:

• Neurology
• Neuroscience
• Pathology

Background:

• Neuroimaging identifies white matter abnormalities common in dementia, some predicting cognitive decline.
• These abnormalities stem from cerebral vascular diseases or nonstructural vascular issues, neurovascular instability, or extracranial conditions.
• Traditional histopathology often mixes vascular changes with altered fluid dynamics or ischemic damage, obscuring etiology.

Purpose of the Study:

• To integrate neuroimaging, histopathology, and biochemical analysis for a comprehensive understanding of white matter damage in dementia.
• To differentiate between structural and nonstructural vascular causes of white matter abnormalities.
• To provide quantitative data on white matter damage severity, etiology, and pathogenesis.

Main Methods:

• Utilizing neuroimaging techniques to detect white matter abnormalities.
• Employing conventional histopathology to assess white matter morphology.
• Supplementing histopathology with biochemical analyses, including markers for ischemia, myelin damage, microvessel density, blood-brain barrier dysfunction, axonal injury, and white matter damage mediators.

Main Results:

• The combination of methods allows for reproducible, quantitative assessment of white matter damage.
• This integrated approach provides crucial information on the etiology and pathogenesis of white matter abnormalities.
• Identified abnormalities correlate with cognitive decline and contribute to dementia, especially in cases of white matter hypoperfusion.

Conclusions:

• Integrating neuroimaging, histopathology, and biochemical analysis enhances the understanding of white matter damage in dementia.
• This comprehensive approach can differentiate causes and quantify damage severity, aiding in treatment development.
• Improved understanding of white matter hypoperfusion's role in dementia can lead to more effective therapeutic strategies.